Skip to content
Education
KZActiveBIN 080440000088
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ РЕПРОДУКТИВНОЙ МЕДИЦИНЫ"

Director
Джусубалиева Тамара Муфтаховна
Incorporated
01.04.2008
Address
Алматы ул. ТОЛЕ БИ, 99/40
РНН
600700601437

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ РЕПРОДУКТИВНОЙ МЕДИЦИНЫ"
BIN
080440000088
Status
Active
Director
Джусубалиева Тамара Муфтаховна
Registration date
01.04.2008
Activity
Прочая деятельность в области образования, не включенная в другие группировки
Legal address
Алматы ул. ТОЛЕ БИ, 99/40

In government contracts over 2 years

VAT payer
No
КАТО
751110000
РНН
600700601437
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – НКО
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
85599primary

Прочая деятельность в области образования, не включенная в другие группировки

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
642.3K
2025
1.2M+46%
2024
802.9K-8%
2023
873.2K+11%
2022
788.6K+171%
2021
291.3K
·642.3K
2026year to date
+46%1.2M
2025
-8%802.9K
2024
+11%873.2K
2023
+171%788.6K
2022
·291.3K
2021
2026
Tax paid642,258 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid1,169,788 ₸
Penalty0 ₸
Fine27,524 ₸
VAT refund0 ₸
2024
Tax paid802,918 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid873,225 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid788,613 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid291,316 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • ДТ

    Джусубалиева Тамара Муфтаховна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

УЧРЕЖДЕНИЕ "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ РЕПРОДУКТИВНОЙ МЕДИЦИНЫ" (BIN 080440000088) is an active legal entity in Алматы, registered in 2008 (18 years on the market). Primary activity — прочая деятельность в области образования, не включенная в другие группировки. Per open government registries as of November 8, 2026: 65 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 20,446,000 ₸. Automated screening of open registries found no risk indicators for "НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ РЕПРОДУКТИВНОЙ МЕДИЦИНЫ". Director on record — Джусубалиева Тамара Муфтаховна. Data current as of November 8, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.